Durvalumab (anti-PD-L1) CAS:1428935-60-7
Durvalumab (anti-PD-L1)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-2220 | 1mg | 265.00 | + Add to cart |
|
| R-C-2220 | 5mg | 625.00 | + Add to cart |
|
| R-C-2220 | 25mg | 2020.00 | + Add to cart |
|
|
|
||||
Product description
Durvalumab(MEDI 4736)is an humanized anti-PD-L1 monoclonal antibody.Durvalumab (MEDI4736)completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04nM,respectively.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 2 years |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---Durvalumab (anti-PD-L1)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


